首页> 外国专利> Arilpropionamida arilacrilamida arilpropinamida or arilmetilurea derivatives as inhibitors of factor XIa. Extraction process and Pharmaceutical compositions.

Arilpropionamida arilacrilamida arilpropinamida or arilmetilurea derivatives as inhibitors of factor XIa. Extraction process and Pharmaceutical compositions.

机译:阿里普利安尼达arilacrilamida阿里普利尼达或阿勒美脲作为XIa因子的抑制剂。提取过程和药物成分。

摘要

This table refers to formula compound (1),There is also drug synthesis that includes these compounds and methods of treating thrombosis and / or inflammation, using the same and the same acquisition process. Item 1: a compound with formula characteristics,1. A is a c3-10 carbohydrate, which is replaced by 0-1r1 and 0-3r2, or different cycles of 5-12 members, including: carbon atom and 1-4 heteroatom selected from n, or s (or) p; Where the heterocycle is replaced by 0-1r1 and 0-3r2, the condition is that when a is a heterocycle containing one or more nitrogen atoms, a is not connected to L1; L1 es-ch2ch2 - through any nitrogen element in ring a.-CH (NR7R8) CH2--CH=CH---CSC...- er...-CR5R6NH, -CH2O-,-Sch2...-SO2CH2...-CH2N10...I am me!If L1 is - CH2O,A is then another compound different from the unsubstituted phenyl; m is a component of the formula group (2);R1 is independently each that occurs. F, Cl, Br, I, OCF3, CF3, - (CH2) rORa, - (CH2) rSRa, CN, - (CH2) rNR7R8, -C (= NR8) NR8R9, -C (O) NR8R9, -S ( O) pNR8R9, or C1-6 alkyl substituted with 0-1 R1a; R1a is F, OCF3, CF3, ORa, SRa, CN, -NR7R8, -C (O) NR8R9, -NR8C (O) Rc, -S (O) pNR8R9, NR8SO2Rc, or (CF2) rCF3; R2 is, independently each one presented, O, F, CI, Br, OCF3, CF3, CHF2, CN, NO2 (CH2) rORa, (CH2) rSRa, -C (O) Ra, -C (O) ORa, -OC (O) Ra, - (CH2) NR7R8, -C (O) NR8R9, NR8C (O) Rc, NR8C (O) ORc, NR8C (O) NR8Rc, -S (O) pNR8R9, -NR8S (O) pRc, -S (O) Rc, -S (O) 2Rc, C1-6 alkyl substituted with 0-1 R2a, (CH2) 3-7 membered r-carbocycle optionally substituted with 0-2 R2b,or - (CH2) 5-7 membered r-heterocycle comprising carbon atoms and 1-4 heteroatoms selected from N, O, and S (O) p, wherein the heterocycle is substituted with 0-2 R2b; alternatively, when the R1 and R2 groups are substituted into adjacent atoms which can be taken together with the atoms to which they are attached to form a 5- to 7-membered carbocycle or heterocycle comprising carbon atoms and 0-4 heteroatoms selected from N , O, and S (O) p and substituted with 0-2 Rg; R2a is F, OCF3, CF3, ORa, SRa, CN, -NR7R8, -C (O) NR8R9, -NR8C (O) Rc, - NR8C (O) ORc, -NR8C (O) NR8Rc, S (O) pNR8R9 , -NR8SO2Rc, or (CF2) rCF3; R2b is independently each that occurs, = O, F, Br, CI,OCF3, CF3, - (CH2) rORa, - (CH2) rSRa, - (CH2) rCN, - (CH2) rNR7R8, - (CH2) rC (O) ORa, (CH2) rC (O) NR8R9, - (CH2 ) rNR8C (O) Rc, - (CH2) rNR8C (O) ORc, - (CH2) rS (O) pNR8R9, - (CH2) rNR8SO2Rc, C1-4 alkyl or (CF2) rCF3; R3 is, independently at each occurrence, - (CH2) r-carboxy C3-10 substituted with 0-3 R3a and 0-1 R3d, or - (CH2) r-heterocycle with 5 to 12 members, comprising: carbon atoms and 1-4 heteroatoms selected from N, O, and S (O) p, where the heterocycle is substituted with 0-3 R3a and 0-1 R3d; R3a is, independently each occurring, = O, = NR8, F, CI, Br, I, OCF3, CF3, - (CH2) rCN, NO2, - (CH2) rOR3b, - (CH2) rSR3b, - (CH2 ) rNR7R8, -NHC (O) NR8R9, - (CH2) rC (O) OR3b, -C (O) C1-4alkyl, -SO2NHR3b,-SO2NHCORc, -SO2NHCO2Rc, -CONHSO2R3c, - (CH2) rNR8C (O) R3b, - (CH2) rNR8CO2R3c, (CH2) rS (O) pNR8R9, - (CH2) rNR8S (O) pR3C, -NHS O) R3c, S (O) 2R3c, - (CH2) rC (O) NR8R9, - (CH2) rOC (O) NR8R9, -NHCOCF3, -NHSO2R3c, CONHOR3b, C1-4 haloalkyloxy, C1-4alkyl -6 substituted by R3e, C2-6 alkenyl substituted by R3e, C1-6 alkynyl substituted by R3e, C3-6 cycloalkyl substituted by 0-1 R3d, (CH2) r-carbocycle C6-10 replaced by 0-3 R3d or - (CH2) 5 to 10 membered r-heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, O, and S (O) p, wherein the heterocycle is substituted with 0-3 R3d; alternatively,When two R3a groups are substituted into adjacent atoms, they can be taken together with the atoms to which they bond to form a 0-2 R3d-substituted C3-10 carbocycle, or a 5-10 membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, O, and S (O) p, wherein the heterocycle is substituted with 0-2 R3d; R3b is, independently at each occurrence, H, C1-2 alkyl substituted with 0-2 R3d, C2-6 alkenyl substituted with 0-2 R3d, C2-6 alkynyl substituted with 0-2 R3d, - (CH2) r- C3-10 carbocycle substituted with 0-3 R3d,o - (CH2) r-heterociclo de 5 hasta 10 miembros que comprende tomos de carbono y 1-4 hetero tomos seleccionados de NO y S (O) p en donde el heterociclo est substituido con 0-3 R3d R3c es independientemente cada que se -C (O) ORa, -OC (O) Ra, NR8C (O) Rc, -C (O) NR8R9, - S (O) 2NR8R9, -NR7R8, NR8S (O) 2NR8R9, NR8S (O) 2Rc, - S (O) pRc, - (CF2) rCF3, C1-6 alkyl substituted with 0-2 Re, C2-6 alkenyl substituted with 0-2 Re, C2-6 alkynyl substituted with 0-2 Re, - (CH2) r -C3-10 carbocycle substituted with 0-3 Rd, or (CH2) r 5 to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, O, and S (O) p, where the heterocycle is substituted with 0-3 Rd; R3e is, independently each one presented, H, - (CH2) rORa, F, = O, CN, NO2, - (CH2) rNR7R8, -C (O) Ra, -C (O) ORa, - OC (O ) Ra, NR8C (O) Rc, -C (O) NR8R9, -S (O) 2NR8R9, NR8S (O) 2NR8R9, NR8S (O) 2Rc, -S (O) pRc, (CF2) rCF3,(CH2) C3-10 r-carbocycle substituted with 0-3 Rd, or - (CH2) 5-10 membered r-heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, O, and S (O ) p, where the heterocycle is substituted with 0-3 Rd; R4 is, independently each occurring, H, F, CI, Br, I, OCF3, CF3, CN, NO2, ORa, SRa, -C (O) Ra, -C (O) ORa, -OC (O) Ra, -NR7R8, -C (O) NR8R9, -NR8C (O) Rc, - S (O) pNR8R9, -NR8S (O) pRc, -S (O) 2Rc, or C1-4 alkyl substituted with 0-2 R4a; R4a is, independently each occurring, H, F, = O, C1-6 alkyl, ORa, SRa, CF3, CN, NO2, -C (O) Ra, -C (O) ORa, -NR7R8, -C (O) NR8R9, -NR8C (O) Rc, -S (O) pNR8R9, -NR8S (O) pRc, - S (O) Rc, or -S (O) 2Rc; R5 is,independently each occurring, H, F, CF3, - (CH2) rORa, = O, - (CH2) r-NR7R8, -S (O) pNR8R9, - (CH2) r-CO2Ra, - (CH2) r- CONR8R9, or C1-4 alkyl; R6 is, independently each occurring, H, F, or C1-4alkyl; R7 is, independently each occurring, H, C1-6alkyl, - (CH2) n-carbocycle C3-10, - (CH2) n- (5- to 10-membered heteroaryl),C (O) Rc, -CHO, -C (O) 2Rc, -S (O) 2Rc, -CONR8Rc, -OCONHRc, -C (O) O- (C1-4alkyl) OC (O) - (C1alkyl -4),O-C (o) or - (C1-4 tar) OC (o) - (arilo C6-10);Where 0-2 RF is used to replace tar, carbohydrate, isopropene and arilo, isopropene includes: carbon atom and 1-4 heteroatoms selected from n, O, y (o) p; R8 is, regardless of each case, h, C1-6, n-fenilo, O-2, N-Heterocycle, consisting of 5 to 10 members: carbon atom And 1-4 heteroatoms selected from n, O, and S (o) P, in which tar, phenyl, and heteroatoms can be replaced by 0-2 RF; or, R7 and R8, when combined with the same nitro group, can be combined into a different cycle of 5-10 members, including: carbon atoms and 0-3 extra heteroatoms selected from n.O. And S (o) P, in which the heterocycle is replaced by 0-2 RF; R8a is h or C1-4 tar; R9 is independently occurring C1-6 or N - (CH2) phenyl; where tar and phenyl are replaced by 0-2 RF; on the other hand, R8 and R9, when they are linked to the same nitro group, are combined into a heterocycle. It is composed of 5 to 10 members: carbon atom and other 0-2 heteroatom selected from n, O, and S (o) P, in which case, heterocycle is replaced by 0-2rd; R10 is h or C1-6 tar, regardless of each case, it is replaced by 0-3r10a; r10a is, regardless of each case, H = or C1-4 tar, ora,F, CF3, CN, NO2, -C (O) Ra, -C (O) ORa, -C (O) NR8R9, -NR8C (O) Rc, -S (O) pNR8R9, - NR8S (O) pRc, or S (O) pRc; R11 is C1-4 haloalkyl, -C (O) NR8R9, -CH2C (O) NR8R9, -CH2CH2C (O) NR8R9, -C (O) Ra, -CH2C (O) Ra, -CH2CH2C (O) Ra, - C (O) ORa, -CH2C (O) ORa, -CH2CH2C (O) ORa, C1-3 alkyl substituted with 0-3 R11c, C2-6 alkenyl substituted with 0-3 R11a, C2-6 alkynyl or substituted with 0 -3 R11a, - (CH2) r-C3-10 carbocycle substituted with 0-3 R11b, or - (CH2) r-heterocycle with 5 to 10 members, comprising: carbon atoms and 1-4 heteroatoms selected from N, O , and S (O) p, where the heterocycle is substituted with 0-3 R11b; R11a is, independently every H, = O, ORa, SRa, F, CF3, CN, NO2, -C (O) Ra,-, or 1-1, or 1-carbon-1-1-1-1 atoms, including 1, or carbon-1-1-carbon-1, or carbon - heteromorphic atoms selected from n, O, and S (o) P, and C1C (or (or) PRC, C1C, c1c1c, any kind of C1C, any kind of C6, or C1C, any kind of C3-6, C1-4 halide, C1-4 halide,-(CH2) r-carbocyclo c3-10 is changed to 0-3 Rd, or - (CH2) r-heterocycle is composed of 5 to 10 members, including carbon atoms and 1-4 heteroatoms selected from n, O, s (o) P, and replaced by 0-3 Rd; or
机译:该表涉及式化合物(1)。还有一些药物合成,包括这些化合物以及使用相同和相同的获取过程来治疗血栓形成和/或炎症的方法。第1项:具有分子式特征的化合物1。 A是c3-10碳水化合物,其被0-1r1和0-3r2或5-12个成员的不同环所取代,包括:碳原子和选自n或s(或)p的1-4个杂原子;当杂环被0-1r1和0-3r2取代时,条件是a为含有一个或多个氮原子的杂环时,a不与L1连接; L1 es-ch2ch2-通过环a.-CH中的任何氮元素-CH(NR7R8)CH2--CH = CH --- CSC ...- er ...- CR5R6NH,-CH2O-,-Sch2 ...- SO2CH2 ...- CH2N10 ...我是我!如果L1是-CH2O,A是另一种与未取代的苯基不同的化合物; m是式组(2)的组分; R 1独立地是各自出现的。 F,Cl,Br,I,OCF3,CF3,-(CH2)rORa,-(CH2)rSRa,CN,-(CH2)rNR7R8,-C(= NR8)NR8R9,-C(O)NR8R9,-S( O)pNR8R9,或被0-1个R1a取代的C1-6烷基; R1a是F,OCF3,CF3,ORa,SRa,CN,-NR7R8,-C(O)NR8R9,-NR8C(O)Rc,-S(O)pNR8R9,NR8SO2Rc或(CF2)rCF3; R 2分别独立地为O,F,Cl,Br,OCF3,CF3,CHF2,CN,NO2(CH2)rORa,(CH2)rSRa,-C(O)Ra,-C(O)ORa,- OC(O)Ra,-(CH2)NR7R8,-C(O)NR8R9,NR8C(O)Rc,NR8C(O)ORc,NR8C(O)NR8Rc,-S(O)pNR8R9,-NR8S(O)pRc ,-S(O)Rc,-S(O)2Rc,被0-1 R2a取代的C1-6烷基,(CH2)3-7元r-碳环,可选地被0-2 R2b取代或-(CH2)5包含碳原子和选自N,O和S(O)p的1-4个杂原子的-7元r-杂环,其中杂环被0-2个R2b取代;或者,当R1和R2基团被取代成相邻的原子时,相邻的原子可以与它们所连接的原子一起形成5至7元的碳环或包含碳原子和选自N的0-4杂原子的杂环。 O和S(O)p并被0-2 Rg取代; R2a是F,OCF3,CF3,ORa,SRa,CN,-NR7R8,-C(O)NR8R9,-NR8C(O)Rc,-NR8C(O)ORc,-NR8C(O)NR8Rc,S(O)pNR8R9 ,-NR8SO2Rc或(CF2)rCF3; R 2b独立地各自出现,= O,F,Br,Cl,OCF3,CF3--(CH2)rORa,-(CH2)rSRa,-(CH2)rCN,-(CH2)rNR7R8,-(CH2)rC( O)ORa,(CH2)rC(O)NR8R9,-(CH2)rNR8C(O)Rc,-(CH2)rNR8C(O)ORc,-(CH2)rS(O)pNR8R9,-(CH2)rNR8SO2Rc,C1 -4烷基或(CF2)rCF3; R3在每次出现时独立地是-(CH2)r-羧基C3-10被0-3 R3a和0-1 R3d取代,或-(CH2)r-杂环具有5-12个成员,包括:碳原子和1选自N,O和S(O)p的-4个杂原子,其中杂环被0-3 R3a和0-1 R3d取代; R 3a独立地分别为= O,= NR8,F,Cl,Br,I,OCF3,CF3,-(CH2)rCN,NO2,-(CH2)rOR3b,-(CH2)rSR3b,-(CH2)rNR7R8 ,-NHC(O)NR8R9,-(CH2)rC(O)OR3b,-C(O)C1-4烷基,-SO2NHR3b,-SO2NHCORc,-SO2NHCO2Rc,-CONHSO2R3c,-(CH2)rNR8C(O)R3b,- (CH2)rNR8CO2R3c,(CH2)rS(O)pNR8R9,-(CH2)rNR8S(O)pR3C,-NHS O)R3c,S(O)2R3c,-(CH2)rC(O)NR8R9,-(CH2) rOC(O)NR8R9,-NHCOCF3,-NHSO2R3c,CONHOR3b,C1-4卤代烷氧基,被R3e取代的C1-4烷基-6,被R3e取代的C2-6烯基,被R3e取代的C1-6炔基,被R3e取代的C3-6环烷基0-1 R3d,(CH2)r-碳环C6-10被0-3 R3d取代或-(CH2)5至10元的r-杂环,包括:碳原子和1-4个选自N,O和S的杂原子( O)p,其中杂环被0-3 R3d取代;或者,当两个R 3a基团被取代成相邻原子时,它们可与它们所键合的原子一起形成0-2个R 3d取代的C 3-10碳环或5-10元杂环,其包含:碳原子和选自N,O和S(O)p的1-4个杂原子,其中杂环被0-2个R3d取代; R3b在每次出现时独立地是H,被0-2 R3d取代的C1-2烷基,被0-2 R3d取代的C2-6烯基,被0-2 R3d取代的C2-6炔基,-(CH2)r- C3 -10个被0-3 R3d,o-(CH2)r-heterocicloclo de 5 hasta取代的碳环化合物1-4个杂原子0-3 R3d R3c是独立的-C(O)ORa,-OC(O)Ra,NR8C(O)Rc,-C(O)NR8R9,-S(O)2NR8R9,-NR7R8,NR8S(O )2NR8R9,NR8S(O)2Rc,-S(O)pRc,-(CF2)rCF3,被0-2 Re取代的C1-6烷基,被0-2 Re取代的C2-6烯基,被0-2 Re取代的C2-6炔基0-2 Re,-(CH2)r -C3-10碳环,被0-3 Rd取代,或(CH2)r 5至10元杂环,包括:碳原子和1-4个选自N,O和S的杂原子(O)p,其中杂环被0-3 Rd取代; R 3e分别独立地为H,-(CH2)rORa,F,= O,CN,NO2,-(CH2)rNR7R8,-C(O)Ra,-C(O)ORa,-OC(O) Ra,NR8C(O)Rc,-C(O)NR8R9,-S(O)2NR8R9,NR8S(O)2NR8R9,NR8S(O)2Rc,-S(O)pRc,(CF2)rCF3,(CH2)C3-10被0-3 Rd取代的r-碳环或-(CH2)5-10元的r-杂环,包括:碳原子和1-4个选自N,O和C的杂原子S(O)p,其中杂环被0-3 Rd取代; R4分别独立地为H,F,Cl,Br,I,OCF3,CF3,CN,NO2,ORa,SRa,-C(O)Ra,-C(O)ORa,-OC(O)Ra, -NR7R8,-C(O)NR8R9,-NR8C(O)Rc,-S(O)pNR8R9,-NR8S(O)pRc,-S(O)2Rc或被0-2 R4a取代的C1-4烷基; R 4a各自独立地为H,F = O,C 1-6烷基,ORa,SRa,CF 3,CN,NO 2,-C(O)Ra,-C(O)ORa,-NR 7 R 8,-C(O )NR8R9,-NR8C(O)Rc,-S(O)pNR8R9,-NR8S(O)pRc,-S(O)Rc或-S(O)2Rc; R 5独立地分别是H,F,CF3--(CH2)rORa,= O,-(CH2)r-NR7R8,-S(O)pNR8R9,-(CH2)r-CO2Ra,-(CH2)r -CONR8R9或C1-4烷基; R 6各自独立地为H,F或C 1-4烷基; R 7各自独立地是H,C 1-6烷基,-(CH 2)正-碳环C 3-10,-(CH 2)n-(5至10元杂芳基),C(O)R c,-CHO,- C(O)2Rc,-S(O)2Rc,-CONR8Rc,-OCONHRc,-C(O)O-(C1-4烷基)OC(O)-(C1烷基-4),OC(o)或-(C1 -4焦油)OC(o)-(芳基C6-10);其中0-2 RF用于取代焦油,碳水化合物,异丙烯和芳基,异丙烯包括:碳原子和1-4个选自n,O,y的杂原子(o)p; R8在任何情况下均为h,C1-6,n-fenilo,O-2,N-杂环,由5至10个成员组成:碳原子和1-4个选自n,O和S的杂原子(o )P,其中的焦油,苯基和杂原子可以被0-2 RF取代;或者,当R 7和R 8与相同的硝基结合时,可以结合成5-10个成员的不同环,包括:碳原子和选自n.O的0-3个额外的杂原子。 S(o)P,其中杂环被0-2 RF取代; R8a是h或C1-4焦油; R9独立地为C1-6或N-(CH2)苯基;焦油和苯基被0-2 RF取代;另一方面,当R 8和R 9连接至相同的硝基时,它们被合并为杂环。它由5到10个成员组成:碳原子和其他选自n,O和S(o)P的0-2杂原子,在这种情况下,杂环被0-2rd取代; R10为h或C1-6焦油,无论哪种情况,均由0-3r10a代替;不论哪种情况,r10a均为H =或C1-4焦油,ora,F,CF3,CN,NO2,-C(O)Ra,-C(O)ORa,-C(O)NR8R9,-NR8C( O)Rc,-S(O)pNR8R9,-NR8S(O)pRc或S(O)pRc; R11为C1-4卤代烷基,-C(O)NR8R9,-CH2C(O)NR8R9,-CH2CH2C(O)NR8R9,-C(O)Ra,-CH2C(O)Ra,-CH2CH2C(O)Ra,- C(O)ORa,-CH2C(O)ORa,-CH2CH2C(O)ORa,被0-3 R11c取代的C1-3烷基,被0-3 R11a取代的C2-6烯基,C2-6炔基或被0取代-3 R11a,-被0-3 R11b取代的(CH2)r-C3-10碳环,或-具有5至10个成员的(CH2)r-杂环,包括:碳原子和1-4个选自N,O, S(O)p,其中杂环被0-3 R11b取代; R11a独立地为每个H = O,ORa,SRa,F,CF3,CN,NO2,-C(O)Ra,-或1-1或1-碳-1-1-1-1原子,包括1或碳1-1-碳-1或选自n,O和S(o)P的碳-多态原子,以及C1C(或(或)PRC,C1C,c1c1c,任何一种C1C,任何种类的C6或C1C,任何种类的C3-6,C1-4卤化物,C1-4卤化物,-(CH2)r-碳环c3-10都更改为0-3 Rd或-(CH2)r-杂环由5至10个成员组成,包括碳原子和1-4个选自n,O,s(o)P的杂原子,并被0-3 Rd取代;或

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号